Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Sep 14;67(36):1017-1018.
doi: 10.15585/mmwr.mm6736a5.

Notes from the Field: Enterovirus A71 Neurologic Disease in Children - Colorado, 2018

Kevin Messacar, Alexis Burakoff, W Allan Nix, Shannon Rogers, M Steven Oberste, Susan I Gerber, Emily Spence-Davizon, Rachel Herlihy, Samuel R Dominguez
Case Reports

Notes from the Field: Enterovirus A71 Neurologic Disease in Children - Colorado, 2018

Kevin Messacar et al. MMWR Morb Mortal Wkly Rep. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

All authors have completed and submitted the ICMJE form for disclosure of potential conflicts of interest. M.S. Oberste has been issued the following patents: U.S. patent no. 7,435,539 for typing of human enteroviruses and U.S. patent no. 6,846,621 for typing of human enteroviruses. W.A. Nix and M.S. Oberste have been issued the following US patents: U.S. patent no. 7,714,122 for kits including VP1 and VP3 nucleic acid molecules for detecting and identifying enteroviruses; U.S. patent no. 7,247,457 for detection and identification of enteroviruses by seminested amplification of the enterovirus VP1 protein; U.S. patent no. 8,048,630; and U.S. patent no. 2,651,123 for methods and agents for detecting parechovirus. K. Messacar reports grants from National Institutes of Health NIAID grant 1K23AI128069-01, during the conduct of the study. No other potential conflicts of interest were disclosed.

References

    1. Nix WA, Oberste MS, Pallansch MA. Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens. J Clin Microbiol 2006;44:2698–704. 10.1128/JCM.00542-06 - DOI - PMC - PubMed
    1. Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ, Solomon T. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol 2010;9:1097–105. 10.1016/S1474-4422(10)70209-X - DOI - PubMed
    1. Khetsuriani N, Lamonte-Fowlkes A, Oberst S, Pallansch MA. Enterovirus surveillance—United States, 1970–2005. MMWR Surveill Summ 2006;55(No. SS-8). - PubMed
    1. Huang CC, Liu CC, Chang YC, Chen CY, Wang ST, Yeh TF. Neurologic complications in children with enterovirus 71 infection. N Engl J Med 1999;341:936–42. 10.1056/NEJM199909233411302 - DOI - PubMed
    1. Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis 2010;10:778–90. 10.1016/S1473-3099(10)70194-8 - DOI - PubMed

Publication types